Lack of correlation between timing of surgery in relation to the menstrual cycle and prognosis of premenopausal patients with early breast cancer

European Journal of Cancer

Volumn 35, Issue 9, 1999, Pages 1326-1330

  Nomura, Y ^a   Kataoka, A ^a   Tsutsui, S ^a   Murakami, S ^a   Takenaka, Y ^a  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

Author keywords

Breast cancer; Menstrual phase; Premenopausal; Prognostic factor; Timing of surgery

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLICULAR PHASE; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MASTECTOMY; MENSTRUAL CYCLE; MENSTRUATION; PREMENOPAUSE; PRIORITY JOURNAL;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLICULAR PHASE; HUMANS; LUTEAL PHASE; MASTECTOMY; MENSTRUAL CYCLE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREMENOPAUSE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 0033198084     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(99)00146-X     Document Type: Article

References (21)

1. Hrushesky W.J.M., Bluming A.Z., Gruber S.A., Sothern R.B. Menstrual influence of surgical cure of breast cancer. Lancet. 2:1989;949-952.
2. Badwe R.A., Gregory W.M., Chaudry M.A.et al. Timing of surgery during menstrual cycle and survival of premenopausal women with operable breast cancer. Lancet. 337:1991;1261-1264.
3. Senie R.T., Rosen P.P., Rhodes P., Lesser M.L. Timing of breast cancer excision during the menstrual cycle influences duration of disease-free survival. Ann. Internal Med. 115:1991;337-342.
4. Gnant M.F.X., Seifert M., Jakesz R., Adler A., Mittelboeck M., Sevelda P. Breast cancer and timing of surgery during menstrual cycle. A 5-year analysis of 385 premenopausal women. Int J Cancer. 52:1992;707-712.
5. Holli K., Isola J., Hakama M. Prognostic effect of timing of operation in relation to menstrual phase of breast cancer patient - fact or fallacy. Br. J. Cancer. 71:1995;124-127.
6. Jaeger W., Sauerbrei W. Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients. Breast Cancer Res Treat. 34:1995;279-287.
7. Powles T.J., Jones A.L., Ashley S., Tidy A. Menstrual effect on surgical cure of breast cancer. Lancet. 2:1989;1343-1344.
8. Veronesi U., Luini A., Mariani Let al. Effect of menstrual phase on surgical treatment of breast cancer. Lancet. 343:1994;1545-1547.
9. Harlap S., Zauber A.G., Pollack D.M.et al. Survival of premenopausal women with breast carcinoma. Effects of menstrual timing of surgery. Cancer. 83:1998;76-88.
10. McGuire W.L., Hilsenbeck S., Clark G.M. Optimal mastectomy timing. J. Natl. Cancer Inst. 84:1992;346-348.
11. Sauerbrei W., Jaeger W. Timing of breast cancer surgery - some arguments that there is no effect. Ann. Oncol. 5:1994;25-27.
12. Hagen A.A., Hrushesky W.J.M. Menstrual timing of breast cancer surgery. Am. J. Surg. 104:1998;245-261.
13. Nomura Y., Shirouzu M., Takayama T. Direct comparisons of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer patients stratified by estrogen receptor and menopausal status. Breast Cancer Res. Treat. 49:1998;51-60.
14. SAS: The Npar1way procedure, SAS/STAT Software: changes and enhancements through Release 6.11, 1996, 771-780.
15. The Lifetest procedure. SAS/STAT User's Guide,Version 6, Fourth Edition, 1990, 1027-1069.
16. The Phreg procedure. SAS Technical Report P-217, SAS/STAT Software, 1991, Version 6, 1-59.
17. Badwe R.A., Wang D.Y., Gregory W.M.et al. Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. Eur. J. Cancer. 30A:1994;445-448.
18. Silvestrini R., Luisi A., Daidone M.G., Di Mauro M.G. Effect of menstrual phase on cell proliferative rate of breast cancer. Breast Cancer Res. Treat. 48:1998;93-94.
19. Saad Z., Bramwell V.H.C., Wilson S.M., O'Malley F.P., Jeacock J., Chambers A.F. Expression of genes that contribute to proliferative and metastatic ability in breast cancer resected during various menstrual phases. Lancet. 351:1998;1170-1173.
20. Cooper L.S., Gillett C.E., Smith P., Fentiman I.S., Barnes D.M. Cell proliferation measured by MIB1 and timing of surgery for breast cancer. Br. J. Cancer. 77:1998;1502-1507.
21. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomized trials involving 31000 recurrences and 24000 deaths among 75000 women. Lancet. 339:1992;1-15. , 71-85.